Sol-Gel Technologies (NASDAQ:SLGL) Shares Down 0.1% – Should You Sell?

Sol-Gel Technologies Ltd. (NASDAQ:SLGL)’s share price traded down 0.1% during mid-day trading on Tuesday . The stock traded as low as $7.19 and last traded at $7.58. 2,418 shares changed hands during trading, a decline of 92% from the average session volume of 30,800 shares. The stock had previously closed at $7.59.

Sol-Gel Technologies Stock Down 0.1%

The firm has a market capitalization of $21.12 million, a P/E ratio of -22.29 and a beta of 1.11. The firm’s 50-day simple moving average is $6.30 and its 200-day simple moving average is $6.86.

Sol-Gel Technologies (NASDAQ:SLGL) last posted its quarterly earnings data on Friday, May 23rd. The company reported ($3.20) earnings per share (EPS) for the quarter. Sol-Gel Technologies had a negative return on equity of 27.17% and a negative net margin of 81.75%. The company had revenue of $1.03 million for the quarter. As a group, analysts expect that Sol-Gel Technologies Ltd. will post -0.28 EPS for the current fiscal year.

Institutional Investors Weigh In On Sol-Gel Technologies

A hedge fund recently bought a new stake in Sol-Gel Technologies stock. Raymond James Financial Inc. acquired a new stake in shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 108,990 shares of the company’s stock, valued at approximately $101,000. Raymond James Financial Inc. owned approximately 0.39% of Sol-Gel Technologies at the end of the most recent quarter. Institutional investors own 26.18% of the company’s stock.

About Sol-Gel Technologies

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.